Seventure Partners

A French startup created by CNRS researchers at the Physics and Mechanics of Heterogeneous Media (PMMH) Laboratory in Paris, Aenitis Technologies develops bioprocessing medical devices that use acoustophoresis to separate, manipulate and filter biological elements, with a focus on cell therapy manufacturing such as cell sorting, washing and isolation for cell therapy units and blood banks. The company aims to provide acoustic preparation solutions to streamline cell therapies and advance public health, pursuing leadership in acoustophoresis-based separation.

Founded in 2006, Nexess specializes in developing and selling advanced security management solutions for nuclear and high-risk industrial plants. Its product portfolio includes RFID tags, smart cameras, antenna systems, and software platforms designed to enhance traceability, productivity, and security. Headquartered in Mougins, France, with an additional office in Paris, the company serves clients aiming to improve their operational efficiency and safety.

Founded in Paris, France in 2014, Eligo Bioscience specializes in developing innovative antimicrobials called Eligobiotics. These are protein-based nanodelivery vectors that employ a synthetic circuit encoding for a programmable RNA-guided nuclease, targeting bacteria based on their genome. The company's applications span therapeutics, cosmetics, biodefense, and more.

Founded in Paris, France in 2014, HARDLOOP is an online retailer specializing in sports products. It offers a wide range of items including shoes, gloves, bottles, and other accessories for various adventure sports such as hiking, running, skiing, climbing, and swimming.

Expensya is a Paris-based provider of expense management software that automates professional expense reports across web and mobile platforms. The Expensya platform handles expense capture and processing, approval workflows, data export, accountant integration, archiving, email processing, mileage tracking, cost accounting, and scanning, with analytics. It runs on cloud and uses AI, machine learning, big data, and business intelligence to streamline operations. The solution is available in multiple languages and adapts to local accounting rules in roughly fifty countries. The company was founded in 2014 and is headquartered in Paris, France.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Founded in Paris, France in 2014, HARDLOOP is an online retailer specializing in sports products. It offers a wide range of items including shoes, gloves, bottles, and other accessories for various adventure sports such as hiking, running, skiing, climbing, and swimming.

JobTeaser SARL operates a recruitment platform designed specifically for students and recent graduates. Founded in 2008 and based in Paris, France, the company facilitates the search for internships and entry-level jobs through its online platform, which offers tailored opportunities based on user profiles. JobTeaser is integrated into over 750 educational institutions, providing access to 5 million users and enabling more than 250,000 recruiters to connect with emerging talent. The platform not only assists with job placements but also offers career guidance, videos to explore various career paths, and advice on making informed career choices. Additionally, it includes features that allow direct communication between job seekers and recruiters, enhancing the overall job search experience.

Expensya is a Paris-based provider of expense management software that automates professional expense reports across web and mobile platforms. The Expensya platform handles expense capture and processing, approval workflows, data export, accountant integration, archiving, email processing, mileage tracking, cost accounting, and scanning, with analytics. It runs on cloud and uses AI, machine learning, big data, and business intelligence to streamline operations. The solution is available in multiple languages and adapts to local accounting rules in roughly fifty countries. The company was founded in 2014 and is headquartered in Paris, France.

Launchmetrics is a marketing and analytics platform that specializes in serving the fashion, luxury, and beauty industries. Founded in 2006 and headquartered in New York, with additional operations in Paris, the company offers a suite of products designed to enhance brand performance and streamline marketing processes. Its offerings include Samples, Events, Contacts, Discover, and Influencers by Launchmetrics, which collectively assist brands in planning product launches and improving media performance. The company has established itself as a trusted technology provider, working with over 1,000 clients, including prominent names like Dior, Fendi, and NET-A-PORTER, as well as partners such as the British Fashion Council and Google. With a presence in eight markets and support in five languages, Launchmetrics aims to empower brands to create impactful and measurable consumer experiences, adapting to the rapidly changing digital landscape. The company was originally known as Fashion GPS, Inc. before rebranding in January 2016.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Founded in Paris, France in 2014, Eligo Bioscience specializes in developing innovative antimicrobials called Eligobiotics. These are protein-based nanodelivery vectors that employ a synthetic circuit encoding for a programmable RNA-guided nuclease, targeting bacteria based on their genome. The company's applications span therapeutics, cosmetics, biodefense, and more.

Intento Design SA, founded in 2015 and based in Paris, France, specializes in developing software that enhances the efficiency of analog and mixed-signal integrated circuit development. The company's flagship product, ID-Xplore, automates the analog design process from hand analysis to simulation, significantly reducing the time required for circuit sizing. Intento Design also provides services such as methodology adoption, design collaboration, and technology migration. Their solutions are tailored for designers in various markets, including consumer electronics, Internet of Things, big data, military, and medical sectors. The company's innovative approach originated from research conducted at Laboratoire d’Informatique de Paris 6, resulting in a robust portfolio of intellectual property focused on accelerating the design cycle for complex systems-on-chips (SoCs).

Botfuel, established in 2016 and headquartered in Paris, France, specializes in a web-based platform and SDK for creating and deploying chatbots. It empowers individuals and businesses to engage with customers on popular messaging channels, providing automated, personalized support and enhancing brand engagement. The platform leverages AI to develop modular, scalable chatbots, aiming to improve customer support and drive sales.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

MilliDrop Instruments SAS is a Paris-based company that specializes in the design and development of advanced cell culture machines utilizing millifluidics technology for bacteriological research and diagnostics. Established in 2015, MilliDrop focuses on creating innovative in vitro diagnostics instruments, such as the MilliDrop DIV, which facilitate the identification of infectious agents and the determination of appropriate antibiotic dosages. These instruments allow for the incubation, analysis, and manipulation of microscopic samples ranging from approximately 100 nanoliters to a few picoliters in volume. By enabling microbiologists to simultaneously study various cultures, monitor phenotypic diversity, and conduct serial dilutions, MilliDrop enhances the efficiency and accuracy of antimicrobial susceptibility testing across a range of microorganisms, including bacteria, fungi, and yeasts.

Intento Design SA, founded in 2015 and based in Paris, France, specializes in developing software that enhances the efficiency of analog and mixed-signal integrated circuit development. The company's flagship product, ID-Xplore, automates the analog design process from hand analysis to simulation, significantly reducing the time required for circuit sizing. Intento Design also provides services such as methodology adoption, design collaboration, and technology migration. Their solutions are tailored for designers in various markets, including consumer electronics, Internet of Things, big data, military, and medical sectors. The company's innovative approach originated from research conducted at Laboratoire d’Informatique de Paris 6, resulting in a robust portfolio of intellectual property focused on accelerating the design cycle for complex systems-on-chips (SoCs).

Founded in Paris, France in 2014, Eligo Bioscience specializes in developing innovative antimicrobials called Eligobiotics. These are protein-based nanodelivery vectors that employ a synthetic circuit encoding for a programmable RNA-guided nuclease, targeting bacteria based on their genome. The company's applications span therapeutics, cosmetics, biodefense, and more.

A French startup created by CNRS researchers at the Physics and Mechanics of Heterogeneous Media (PMMH) Laboratory in Paris, Aenitis Technologies develops bioprocessing medical devices that use acoustophoresis to separate, manipulate and filter biological elements, with a focus on cell therapy manufacturing such as cell sorting, washing and isolation for cell therapy units and blood banks. The company aims to provide acoustic preparation solutions to streamline cell therapies and advance public health, pursuing leadership in acoustophoresis-based separation.

JobTeaser SARL operates a recruitment platform designed specifically for students and recent graduates. Founded in 2008 and based in Paris, France, the company facilitates the search for internships and entry-level jobs through its online platform, which offers tailored opportunities based on user profiles. JobTeaser is integrated into over 750 educational institutions, providing access to 5 million users and enabling more than 250,000 recruiters to connect with emerging talent. The platform not only assists with job placements but also offers career guidance, videos to explore various career paths, and advice on making informed career choices. Additionally, it includes features that allow direct communication between job seekers and recruiters, enhancing the overall job search experience.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Founded in 2006, Nexess specializes in developing and selling advanced security management solutions for nuclear and high-risk industrial plants. Its product portfolio includes RFID tags, smart cameras, antenna systems, and software platforms designed to enhance traceability, productivity, and security. Headquartered in Mougins, France, with an additional office in Paris, the company serves clients aiming to improve their operational efficiency and safety.

Biophytis SA is a clinical-stage biotechnology company headquartered in Paris, France, dedicated to developing therapeutics aimed at slowing the degenerative processes associated with aging and enhancing functional outcomes for patients with age-related diseases. The company is focused on activating key biological resilience pathways that may protect against the effects of various biological and environmental stresses linked to these diseases. Biophytis's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule designed for treating neuromuscular conditions such as sarcopenia and Duchenne muscular dystrophy. Additionally, its second candidate, Macuneos (BIO201), targets retinal diseases, including age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon to further the development of Sarconeos. Since its founding in 2006, Biophytis has aimed to position itself as a leader in the emerging field of aging science by providing innovative therapies for patients with limited treatment options.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Impeto Medical SAS is a privately owned medical device company established in June 2005, with its headquarters located in Paris, France, and additional subsidiaries in China and San Diego, California. The company specializes in the manufacture and marketing of non-invasive diagnostic devices that assess eccrine sweat gland activity. Its product lineup includes SUDOSCAN+, which is used for detecting and monitoring peripheral autonomic neuropathy; EZSCAN, designed for screening and preventing diabetes and cardio metabolic risks; and SUDOSCAN, a device that evaluates galvanic skin response to assess sympathetic nervous system behavior in various conditions, including diabetes and Parkinson's disease. Impeto Medical's innovative technology enables healthcare professionals to screen large patient populations effectively, facilitating early detection of metabolic disorders and related complications. The company distributes its products through a network of distributors.

Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Founded in Paris in 1993, Arlettie operates as an online retailer specializing in fashion apparel and accessories. It facilitates private sales events for luxury brands, acting as an intermediary between these brands and customers.

Efficity SAS is an online real estate agency located in Paris, France, established in 2007. The company specializes in providing a range of online real estate services, including the buying and selling of properties, property management, and property valuation. Efficity leverages digital platforms to facilitate real estate transactions, enabling clients to navigate the property market efficiently.

Glowria offers online digital video disc (DVD) rental service. Glowria was founded in 2003 is based in Paris, France.

Founded in 1991, Sefas Innovation specializes in collaborative document composition and production software. Headquartered in Paris, France, with offices in the UK and US, it supports over 80 staff globally. Its Open Print software suite enables Fortune 500 companies across financial services, banking, insurance, utilities, telecoms, and public sectors to design, compose, and produce personalized B2C documents from multiple data sources.

DSO Interactive SA designs, develops, and markets software solutions for intermediation of Internet platforms. Its products include auditing and decisional software systems for legal firms. The company also offers information technology and communication consulting services. It was formerly known as Convergence SA and changed its name to DSO Interactive in September 2004. The company was founded in 2001 and is based in Paris, France.